Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo.

Translational psychiatry

Volumn 3, Issue , 2013, Pages

  Kaddurah Daouk, R ^a   Bogdanov, M B ^b   Wikoff, W R ^b   Zhu, H ^b   Boyle, S H ^b   Churchill, E ^b   Wang, Z ^b   Rush, A J ^b   Krishnan, R R ^b   Pickering, E ^b   Delnomdedieu, M ^b   Fiehn, O ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; METABOLOME; MIDDLE AGED; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

ADULT; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METABOLOME; MIDDLE AGED; PLACEBO EFFECT; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880091814     PISSN: None     EISSN: 21583188     Source Type: None    
DOI: 10.1038/tp.2012.142     Document Type: Article

References (0)